Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Dec 31, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Bona fide gift 5,943 --
Dec 31, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 38,498 --
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 27,885 $5.84
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 65,732 $5.84
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 38,498 $4.23
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 90,750 --
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 90,750 $4.23
Dec 22, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Other acquisition or disposition -- --
Dec 18, 2015
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 --
Dec 18, 2015
Director, Chairman & CEO, Ten Percent Owner
Director, Chairman & CEO, Ten Percent Owner Grant, award or other acquisition pursuant to Rule 16b-3(d) 550,000 --
Dec 18, 2015
President & COO
President & COO Grant, award or other acquisition pursuant to Rule 16b-3(d) 500,000 --
Dec 03, 2015
President & COO
President & COO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,710 $5.80
Dec 01, 2015
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 15,000 $4.26
Dec 01, 2015
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,088 $6.00
Dec 01, 2015
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 10,650 $6.00
Dec 01, 2015
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 15,000 --
Oct 29, 2015
President & COO
President & COO Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,710 $5.32
Jul 07, 2015
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 625 $6.96
Jul 07, 2015
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 625 $6.96
Jul 07, 2015
Director
Director Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 625 $6.96

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.